Exagen Inc. (NASDAQ:XGN) Earns a Spot on Our List The Best Penny Stocks Are About to Explode.
As of April 8, 2026, analyst sentiment toward Exagen Inc. (NASDAQ:XGN) remains bullish, with over 80% of covering analysts maintaining “Buy” ratings on the stock. The consensus price target of $10 implies an upside of 235.01%.
On March 11, 2026, Craig-Hallum lowered the stock’s price target to $10 from $12, while issuing a “Buy” rating. The investment firm noted that even though testing volume accelerated for Exagen Inc. (NASDAQ:XGN) as planned, the story did not progress as expected due to average selling prices falling short of projections. As a result, the company does not expect both revenue growth and gross margin to meet initial guidance.
Meanwhile, Exagen Inc. (NASDAQ:XGN) released its Q4 and full-year 2025 results on March 30, 2026, which showed a 20% year-over-year revenue increase, trailing-twelve-month ASP of $441 (+7% year-over-year), and 11% test volume growth.
In addition to highlighting new biomarker additions across its testing platform and guiding 2026 revenue to between $70 million and $73 million, Exagen Inc. (NASDAQ:XGN) reported ending 2025 with $32 million in cash after further strengthening the balance sheet through a public offering and credit facility.
The earnings release highlights the company’s drive toward profitable growth amid margin pressures.
Exagen Inc. (NASDAQ:XGN), a commercial-stage diagnostics company founded by Waneta C. Tuttle and Cole Harris in 2002, transforms the continuum of care for patients suffering from chronic and debilitating autoimmune diseases. It does this by allowing a timely differential diagnosis and optimizing therapeutic intervention.
While we recognize the potential of XGN as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.
READ NEXT: 33 stocks that should double in 3 years and 15 stocks that will make you rich in 10 years.
Disclosure: None. Follow Insider Monkey on Google News.